[HTML][HTML] Non-muscle-invasive bladder cancer: An overview of potential new treatment options
Aim This review article summarizes the current clinical practice guidelines around disease
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer …
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer …
[HTML][HTML] Implications of chromatin modifier mutations in epigenetic regulation of bladder cancer
B Akman, S Erkek-Ozhan - Urologic Cancers [Internet], 2022 - ncbi.nlm.nih.gov
Chromatin deregulation is an emerging theme in cancer pathogenesis, and bladder cancer
stands out among many other cancer types with frequent mutations of genes involved in …
stands out among many other cancer types with frequent mutations of genes involved in …
Nitrated polycyclic aromatic hydrocarbon (nitro-PAH) signatures and somatic mutations in diesel exhaust-exposed bladder tumors
Background: Diesel exhaust is a complex mixture, including polycyclic aromatic
hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and …
hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and …
Nucleocytoplasmic β‐catenin expression contributes to neuroendocrine differentiation in muscle invasive bladder cancer
Bladder cancers are heterogeneous in nature, showing diverse molecular profiles and
histopathological characteristics, which pose challenges for diagnosis and treatment …
histopathological characteristics, which pose challenges for diagnosis and treatment …
Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
Within the heterogeneous population of patients with bacillus Calmette‐Guérin failure, there
are clear differences in prognosis and therapy with regard to the timeline when bacillus …
are clear differences in prognosis and therapy with regard to the timeline when bacillus …
Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma
J Alberto Nakauma-González, M Rijnders, J van Riet… - BioRxiv, 2021 - biorxiv.org
Background Molecular characterization of primary urothelial carcinoma (UC) revealed
molecular subtypes with different genomic, transcriptomic, and clinicopathological …
molecular subtypes with different genomic, transcriptomic, and clinicopathological …
Field cancerization impacts tumor development, T-cell exhaustion and clinical outcomes in bladder cancer
T Strandgaard, I Nordentoft, K Birkenkamp-Demtröder… - bioRxiv, 2023 - biorxiv.org
Bladder field cancerization may be associated with disease outcome in patients with bladder
cancer. To investigate this, we analyzed biopsies from bladder urothelium and urine …
cancer. To investigate this, we analyzed biopsies from bladder urothelium and urine …
Deciphering the role of RBM10 in development and cancer using a genetic mouse model
AM Maldonado Barragán - 2021 - tdx.cat
Short explanation English To reveal how RBM10 loss contributes to development and
cancer we have established Rbm10 constitutive and conditional knockout mouse models …
cancer we have established Rbm10 constitutive and conditional knockout mouse models …
[引用][C] Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility.
Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical
Utility. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
Utility. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …